COMMUNIQUÉS West-GlobeNewswire

Hemostemix Announces Three Additional Sites Enrolled in Phase II Clinical Trial
09/10/2018
CALGARY, Alberta, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“ Hemostemix ” or the “ Company ”) (TSX VENTURE: HEM) is pleased to announce that it has received all approvals from three new medical centers to be [...]
Arbutus Provides Update on HBV Development Programs and Announces Appointment of Dr. Gaston Picchio as Chief Development Officer
09/10/2018
Dr. Mark Murray, Arbutus President & Chief Executive Officer, to participate in a fireside chat at Chardan’s Genetic Medicines Conference at 2:45 pm ET today WARMINSTER, Pa., Oct. 09, 2018 (GLOBE NEWSWIRE) -- [...]
New Data from Adult ADHD Clinical Trial to be Presented at the 65th Annual AACAP Meeting
09/10/2018
Prof. Stephen Faraone, Ph.D. to present on October 25 in Seattle, Washington COLUMBIA, Md., Oct. 09, 2018 (GLOBE NEWSWIRE) -- VAYA™ Pharma, Inc. (VAYA™), a division of Frutarom, Inc., and leader in developing specialty [...]
Ritter Pharmaceuticals Presents Additional Phase 2b Data Showing Adaptation of the Gut Microbiome in Lactose Intolerance Patients at American College of Gastroenterology Scientific Meeting
09/10/2018
LOS ANGELES, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of innovative therapeutic products that modulate the gut microbiome to [...]
CRUZANI Begins Product Development with Cannabis Derivatives for Edible and Infusion Markets
09/10/2018
ATLANTA, Oct. 09, 2018 (GLOBE NEWSWIRE) -- CRUZANI, Inc. (OTC Markets: CZNI) is a global business development company focused on creating and acquiring franchise concepts, along with peripheral food-related businesses [...]
Precision Therapeutics’ Skyline Medical Division Signs International Distribution Agreement with India-based Prenit World
09/10/2018
MINNEAPOLIS, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”) is pleased to announce that its Skyline Medical division, producer of the FDA-approved and CE- [...]
Bellerophon Provides Update on INOpulse® Phase 2b Clinical Program for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
09/10/2018
Enrollment of the Planned 40 Subjects Completed, with Top-line Data Expected in January 2019 WARREN, N.J., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company [...]
Progenics Announces Publication of Pivotal Trial of AZEDRA® (iobenguane I 131) in The Journal of Nuclear Medicine
09/10/2018
NEW YORK, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), an oncology company developing innovative medicines and imaging analysis technology for targeting and treating cancer, today [...]
TESARO Announces Data Presentations at the ESMO 2018 Congress
09/10/2018
WALTHAM, Mass., Oct. 09, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ: TSRO), an oncology-focused biopharmaceutical company, today announced that data from six abstracts will be presented at the European Society for [...]
SUNY Upstate Medical University Selects iCAD’s Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer Treatment
09/10/2018
Premier center becomes first in the region to offer intraoperative radiation therapy with the leading-edge Xoft System to advance quality patient care in New York State NASHUA, N.H. and SYRACUSE, N.Y., Oct. 09, 2018 ( [...]
Mapi Pharma Presents Phase II Extension Results of Glatiramer Acetate Depot (GA Depot) at ECTRIMS 2018 in Berlin
09/10/2018
81.8% Patients on GA Depot Demonstrated No Evidence of Disease Activity (NEDA) at 2 years GA Depot Has Potential to Address Multiple Sclerosis Treatment Burden and Improve Patient Compliance NESS ZIONA, Israel, Oct. 09 [...]
Agile Therapeutics, Inc. Completes Formal Dispute Resolution Process with the FDA
09/10/2018
PRINCETON, N.J., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that it has received a response from FDA’s Office of New Drugs (“OND”) concerning [...]
Poseida Therapeutics Appoints Marcy Graham as Vice President, Corporate Affairs
09/10/2018
SAN DIEGO, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc., a San Diego-based company translating best-in-class gene engineering technologies into lifesaving cell therapies, today announced Marcy Graham has [...]
Ceapro Inc. Receives Approval from Health Canada to Commence Human Clinical Study Assessing Beta Glucan as a Cholesterol-Lowering Agent
09/10/2018
– Ceapro is Pioneering approach with a natural product as add-on therapy to a prescription product – First of the clinical studies being conducted as part of collaboration with the Montreal Heart Institute led by MHI’s [...]
Oryzon announces first patient enrolled in REIMAGINE: a Phase IIa clinical trial with Vafidemstat (ORY-2001) in aggressiveness
09/10/2018
MADRID, Spain and CAMBRIDGE, Mass., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Oryzon Genomics S.A. (ISIN Code: ES0167733015, ORY), (“Oryzon”), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop [...]
Coherus BioSciences Announces New Employment Inducement Grants
09/10/2018
REDWOOD CITY, Calif., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced that effective October 8, 2018, the compensation committee of the company’s board of directors granted 65 [...]
OncoMed Announces Upcoming Presentation of Navicixizumab Interim Phase 1b Data at the European Society of Clinical Oncology Meeting
09/10/2018
REDWOOD CITY, Calif., Oct. 09, 2018 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, today [...]
Medovex Corporation Names William E. Horne Chief Executive Officer and Chairman of the Board
09/10/2018
Seasoned Healthcare Industry Veteran, Founder and Former Chief Executive Officer of Laser Spine Institute to Lead Company Growth Initiative ATLANTA, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Medovex Corp. (OTCQB: MDVX), (" [...]
BioCorRx, Inc. Announces Preliminary Agreement with VDM Biochemicals to Develop and Commercialize Patented Opioid Antagonist VDM-001
09/10/2018
ANAHEIM, CA, Oct. 09, 2018 (GLOBE NEWSWIRE) -- VDM-001 represents potential alternative to naloxone for overdose reversal ; Potential to reduce cravings from substance use disorder via NEWMEDIAWIRE -- BioCorRx Inc. ( [...]

Pages